Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Breast Neoplasms 8Stomach Neoplasms 7Lung Neoplasms 7Small Cell Lung Carcinoma 5Rectal Neoplasms 5Pancreatic Neoplasms 5Colorectal Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Esophageal Squamous Cell Carcinoma 4Recurrence 3NSCLC 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Muscle-invasive Bladder Cancer 2Multiple Myeloma 2Mesothelioma, Malignant 2Limited Stage Small Cell Lung Cancer 2Leukemia, Myeloid, Acute 2Esophageal Neoplasms 2Urologic Neoplasms 1Upper Tract Urothelial Carcinoma 1Thymus Neoplasms 1Sleep Initiation and Maintenance Disorders 1Resectable Non-small Cell Lung Cancer 1Pathologic Complete Response 1

Interventions

pembrolizumab 1peginterferon alfa-2b 1osimertinib 1Radiotherapy 1Pemetrexed 1Interferons 1Drug Therapy 1Cyclophosphamide 1AZD3759 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Meningeal Carcinomatosis × Drug Therapy × Clear all
NCT06766591 2025-01-09

Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs

Jiangsu Province Nanjing Brain Hospital

Phase NA Not yet recruiting
36 enrolled
CNS

Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡